EXAGEN INC. Quarterly Costs and Expenses in USD from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Exagen Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2018 to Q2 2024.
  • Exagen Inc. Costs and Expenses for the quarter ending June 30, 2024 was $17.7M, a 7.35% decline year-over-year.
  • Exagen Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $72.5M, a 17.5% decline year-over-year.
  • Exagen Inc. annual Costs and Expenses for 2023 was $75.4M, a 17.7% decline from 2022.
  • Exagen Inc. annual Costs and Expenses for 2022 was $91.6M, a 26.6% increase from 2021.
  • Exagen Inc. annual Costs and Expenses for 2021 was $72.4M, a 26.6% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $72.5M $17.7M -$1.4M -7.35% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $73.9M $17.4M -$1.52M -8.02% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $75.4M $18.9M -$8.42M -30.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 $83.8M $18.5M -$4.06M -18% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $87.9M $19.1M -$2.62M -12.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $90.5M $18.9M -$1.14M -5.66% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $91.6M $27.3M +$8.39M +44.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 $83.2M $22.5M +$3.79M +20.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $79.4M $21.7M +$3.16M +17% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $76.3M $20.1M +$3.92M +24.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $72.4M $18.9M +$3.51M +22.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 $68.9M $18.8M +$4.19M +28.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 $64.7M $18.5M +$6.15M +49.7% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-11-21
Q1 2021 $58.5M $16.2M +$1.35M +9.11% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $57.2M $15.4M +$2.36M +18% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 $54.8M $14.6M +$1.97M +15.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $52.8M $12.4M -$519K -4.03% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $53.4M $14.8M +$3.67M +33% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $49.7M $13.1M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 $12.6M +$3.24M +34.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $12.9M Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-28
Q1 2019 $11.1M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2018 $9.36M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.